Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma - Leypoldt, Lisa; Tichy, Diana; Besemer, Britta; Hanel, Mathias; Raab, Marc-Steffen; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Gorner, Martin; Ko, Yon-Dschun; Wit, Maike de; et al. (Future oncology, 2024)
Online veröffentlicht: 30. September 2024